Medical use enacted · other possession controlled
New Mexico law protects psilocybin activity only within the Medical Psilocybin Act and its regulated program. Possession outside authorized medical participation remains controlled.

NM legal and access quick reference
Reviewed on September 30, 2026 by iMD teamA concise, source-dated explanation of statewide law, regulated access, and the difference between state and local policy.
Laws and implementation can change quickly. This page is educational information, not legal advice.
New Mexico law protects psilocybin activity only within the Medical Psilocybin Act and its regulated program. Possession outside authorized medical participation remains controlled.
The Department of Health is actively building the Medical Psilocybin Program through rulemaking, advisory-board work, and certification standards. The Department says the program is set to be implemented by December 31, 2026; general enrollment and service access are not yet open.
In 2026, New Mexico advanced producer/laboratory rules and proposed patient, clinician, facilitator, education, and approved-location rules. The Department has stated a goal of enrolling the first patients by the end of December 2026. The framework remains medical and supervised rather than adult-use retail.
New Mexico moved from enactment into active implementation in 2026. The Department of Health held a public hearing on producer and laboratory requirements in April and, in August, published proposed rules covering qualified-patient enrollment and certification of clinicians, practitioners, facilitators, education programs, and approved locations.
The Medical Psilocybin Advisory Board and its committees also met throughout 2026 on dosage, clinical practice, research, equity, training, and end-of-life care. Separately, University of New Mexico School of Medicine researchers began recruiting veterans and first responders with PTSD for a Group Psilocybin-Assisted Therapy study, with plans to expand recruitment later in 2026.
For Albuquerque, Las Cruces and Santa Fe, this New Mexico page is the appropriate quick-reference starting point because no separate municipal action was retained as a distinct local-policy guide. Local rules can change, so verify current official records.
The statewide explanation above covers Albuquerque, Las Cruces and Santa Fe. A separate page appears below only where a documented municipal action adds material local context.
This page was checked against the controlling state statutes, enacted laws, agency records, and official bill histories listed below.
New Mexico has legalized only regulated medical use under the Medical Psilocybin Act. Possession or use outside authorized program activity remains controlled.
A regulated medical program is being implemented, but general enrollment and service access are not yet open. It will be limited to qualified patients and approved program participants, not adult-use retail or dispensary access.
The state moved into active implementation. New Mexico advanced producer and laboratory rules, proposed patient and provider certification rules, convened its Medical Psilocybin Advisory Board and committees, and continued preparing for a targeted first-patient launch by the end of 2026.
Yes. University of New Mexico School of Medicine researchers began recruiting veterans and first responders with PTSD in 2026 for a Group Psilocybin-Assisted Therapy study, with additional recruitment planned later in the year.
No. A local enforcement-priority policy may affect municipal enforcement, but it does not legalize commercial sale, create statewide legality, or override federal law.
The product-site link provides product-format and business-policy information. It does not change the law described on this page or establish legal access in any jurisdiction.